Literature DB >> 23348159

Mechanical and infectious complications developing due to central venous catheterizations in the Emergency Department.

Hayri Ramadan1, Nalan Metin Aksu, Meltem Akkas, Mehmet Husamettin Akkucuk, Figen Coskun, Yesim Cetinkaya Sardan.   

Abstract

AIM: To investigate the rate of catheter-related bloodstream infections (CRBSI) and mechanical complications due to central venous catheter (CVC) insertion in the emergency department (ED) and the contributing factors.
METHODS: A total of 236 patients who were admitted to our ED and underwent CVC insertion between July 2008 and July 2009 were included in this prospective study. The CVC indications, the urgency of the insertion (emergency or elective), catheter complications (mechanical or CRBSI) and the compliance of the emergency physician placing the catheter with infection control and prevention measures were investigated.
RESULTS: The CVC had been inserted urgently in 103 (44%) of the cases and mechanical complication rates in these patients were higher than those receiving it electively (p less 0.05). Our total mechanical complication rate was 27 (11.4%) with the highest rate for femoral catheter (FC). The CRBSI rate was 5/1000 catheter days. None of the physicians inserting a catheter ensured hand hygiene before the procedure.
CONCLUSION: The FC is used as the most common access route for a CVC in our ED but CRBSI rate and mechanical complication rate were lower than in the literature. We believe that increasing compliance with infection control and prevention measures, especially hand hygiene, can further decrease the CRBSI rate in the ED.

Entities:  

Mesh:

Year:  2013        PMID: 23348159

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

1.  Efficacy of two antiseptic regimens on skin colonization of insertion sites for two different catheter types: a randomized, clinical trial.

Authors:  Juergen Thomas Lutz; Isabel Victoria Diener; Kerstin Freiberg; Robert Zillmann; Kija Shah-Hosseini; Harald Seifert; Bettina Berger-Schreck; Hilmar Wisplinghoff
Journal:  Infection       Date:  2016-05-03       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.